Hummingbird Bioscience takes in $125m Series C

Hummingbird Bioscience, a clinical-stage biotech company, has secured $125 million in Series C financing.

Hummingbird Bioscience, a clinical-stage biotech company, has secured $125 million in Series C financing. Novo Holdings led the round with participation.

Source: Press Release